93M1 Stock Overview
An investment company, engages in the healthcare business in Germany. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
MPH Health Care AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €25.20 |
| 52 Week High | €35.60 |
| 52 Week Low | €15.50 |
| Beta | 1.15 |
| 11 Month Change | 1.61% |
| 3 Month Change | 31.94% |
| 1 Year Change | 57.99% |
| 33 Year Change | 7.69% |
| 5 Year Change | -32.44% |
| Change since IPO | 0.76% |
Recent News & Updates
Recent updates
If You Had Bought MPH Health Care's (ETR:93M) Shares A Year Ago You Would Be Down 28%
Aug 10
What Type Of Returns Would MPH Health Care's(ETR:93M) Shareholders Have Earned If They Purchased Their SharesYear Ago?
Aug 10We Think MPH Health Care's (ETR:93M) Statutory Profit Might Understate Its Earnings Potential
Jul 06
Shareholder Returns
| 93M1 | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | 6.8% | -7.0% | -0.4% |
| 1Y | 58.0% | -21.6% | 7.1% |
Return vs Industry: 93M1 exceeded the German Pharmaceuticals industry which returned -21.6% over the past year.
Return vs Market: 93M1 exceeded the German Market which returned 7.1% over the past year.
Price Volatility
| 93M1 volatility | |
|---|---|
| 93M1 Average Weekly Movement | 6.7% |
| Pharmaceuticals Industry Average Movement | 6.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 93M1 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 93M1's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 2 | Patrick Brenske | www.mph-ag.de |
MPH Health Care AG, an investment company, engages in the healthcare business in Germany. The company operates Beauty, Pharma, and Real Estate segments. It offers medicalaesthetic beauty operations and treatments, as well as the operation and provision of medical infrastructures for partner companies; and pharmaceuticals and medical products in the therapeutic areas of oncology, HIV/AIDS, neurology, rheumatology, other chronic diseases, and aesthetic medicine.
MPH Health Care AG Fundamentals Summary
| 93M1 fundamental statistics | |
|---|---|
| Market cap | €103.61m |
| Earnings (TTM) | €119.48m |
| Revenue (TTM) | €118.24m |
0.9x
P/E Ratio0.9x
P/S RatioIs 93M1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 93M1 income statement (TTM) | |
|---|---|
| Revenue | €118.24m |
| Cost of Revenue | €0 |
| Gross Profit | €118.24m |
| Other Expenses | -€1.23m |
| Earnings | €119.48m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Apr 30, 2025
| Earnings per share (EPS) | 27.91 |
| Gross Margin | 100.00% |
| Net Profit Margin | 101.04% |
| Debt/Equity Ratio | 2.6% |
How did 93M1 perform over the long term?
See historical performance and comparison